• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对关键 AD 生物标志物在不同组织中的遗传和蛋白质组学比较。

A genetic and proteomic comparison of key AD biomarkers across tissues.

机构信息

Division of Biology & Biomedical Sciences, Washington University in St. Louis, St. Louis, Missouri, USA.

Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.

出版信息

Alzheimers Dement. 2024 Sep;20(9):6423-6440. doi: 10.1002/alz.14139. Epub 2024 Jul 30.

DOI:10.1002/alz.14139
PMID:39077866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11633343/
Abstract

INTRODUCTION

Plasma has been proposed as an alternative to cerebrospinal fluid (CSF) for measuring Alzheimer's disease (AD) biomarkers, but no studies have analyzed in detail which biofluid is more informative for genetics studies of AD.

METHOD

Eleven proteins associated with AD (α-synuclein, apolipoprotein E [apoE], CLU, GFAP, GRN, NfL, NRGN, SNAP-25, TREM2, VILIP-1, YKL-40) were assessed in plasma (n = 2317) and CSF (n = 3107). Both plasma and CSF genome-wide association study (GWAS) analyses were performed for each protein, followed by functional annotation. Additional characterization for each biomarker included calculation of correlations and predictive power.

RESULTS

Eighteen plasma protein quantitative train loci (pQTLs) associated with 10 proteins and 16 CSF pQTLs associated with 9 proteins were identified. Plasma and CSF shared some genetic loci, but protein levels between tissues correlated weakly. CSF protein levels better associated with AD compared to plasma.

DISCUSSION

The present results indicate that CSF is more informative than plasma for genetic studies in AD.

HIGHLIGHTS

The identification of novel protein quantitative trait loci (pQTLs) in both plasma and cerebrospinal fluid (CSF). Plasma and CSF levels of neurodegeneration-related proteins correlated weakly. CSF is more informative than plasma for genetic studies of Alzheimer's disease (AD). Neurofilament light (NfL), triggering receptor expressed on myeloid cells 2 (TREM2), and chitinase-3-like protein 1 (YKL-40) tend to show relatively strong inter-tissue associations. A novel signal in the apolipoprotein E (APOE) region was identified, which is an eQTL for APOC1.

摘要

简介

已有研究提出用血浆替代脑脊液(CSF)来测量阿尔茨海默病(AD)的生物标志物,但目前尚无研究详细分析哪种生物体液更有助于 AD 的遗传学研究。

方法

在血浆(n=2317)和脑脊液(n=3107)中评估了 11 种与 AD 相关的蛋白(α-突触核蛋白、载脂蛋白 E [apoE]、CLU、GFAP、GRN、NfL、NRGN、SNAP-25、TREM2、VILIP-1、YKL-40)。对每种蛋白进行了血浆和脑脊液全基因组关联研究(GWAS)分析,并进行了功能注释。对每种生物标志物的额外特征分析包括计算相关性和预测能力。

结果

鉴定出与 10 种蛋白相关的 18 个血浆蛋白定量连锁(pQTL)和与 9 种蛋白相关的 16 个 CSF pQTL。血浆和 CSF 具有一些共同的遗传位点,但组织间蛋白水平相关性较弱。CSF 蛋白水平与 AD 的相关性优于血浆。

讨论

本研究结果表明,CSF 比血浆更适合 AD 的遗传研究。

重点

在血浆和脑脊液中均发现了与神经退行性疾病相关蛋白的新型蛋白定量连锁(pQTL)。血浆和 CSF 中神经退行性相关蛋白水平相关性较弱。CSF 比血浆更有助于 AD 的遗传研究。神经丝轻链(NfL)、髓样细胞触发受体 2(TREM2)和几丁质酶-3 样蛋白 1(YKL-40)倾向于表现出较强的组织间相关性。在载脂蛋白 E(APOE)区域鉴定到一个新信号,这是 APOC1 的 eQTL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01a/11633343/32f647b9f3fc/ALZ-20-6423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01a/11633343/30898f52c5f4/ALZ-20-6423-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01a/11633343/1f03c1a39705/ALZ-20-6423-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01a/11633343/32f647b9f3fc/ALZ-20-6423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01a/11633343/30898f52c5f4/ALZ-20-6423-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01a/11633343/1f03c1a39705/ALZ-20-6423-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01a/11633343/32f647b9f3fc/ALZ-20-6423-g001.jpg

相似文献

1
A genetic and proteomic comparison of key AD biomarkers across tissues.对关键 AD 生物标志物在不同组织中的遗传和蛋白质组学比较。
Alzheimers Dement. 2024 Sep;20(9):6423-6440. doi: 10.1002/alz.14139. Epub 2024 Jul 30.
2
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study.与 EMIF-AD 研究中阿尔茨海默病脑脊液生物标志物相关的血液 DNA 甲基化特征。
Alzheimers Dement. 2024 Oct;20(10):6722-6739. doi: 10.1002/alz.14098. Epub 2024 Aug 28.
3
Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study.在一项多中心孟德尔随机化研究中,从血浆和脑脊液蛋白质组中鉴定阿尔茨海默病的潜在治疗靶点。
Int J Biol Macromol. 2025 Mar;294:139394. doi: 10.1016/j.ijbiomac.2024.139394. Epub 2025 Jan 3.
4
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.血浆和脑脊液神经胶质纤维酸性蛋白水平在阿尔茨海默病连续谱中的差异。
JAMA Neurol. 2021 Dec 1;78(12):1471-1483. doi: 10.1001/jamaneurol.2021.3671.
5
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.将痴呆风险基因座与 CSF 蛋白质组相连接,确定痴呆症的病理生理线索。
Brain. 2024 Oct 3;147(10):3522-3533. doi: 10.1093/brain/awae090.
6
The genetic regulation of protein expression in cerebrospinal fluid.脑脊液中蛋白质表达的遗传调控。
EMBO Mol Med. 2023 Jan 11;15(1):e16359. doi: 10.15252/emmm.202216359. Epub 2022 Dec 12.
7
Novel plasma biomarkers of amyloid plaque pathology and cortical thickness: Evaluation of the NULISA targeted proteomic platform in an ethnically diverse cohort.淀粉样斑块病理学和皮质厚度的新型血浆生物标志物:在一个种族多样化队列中对NULISA靶向蛋白质组学平台的评估。
Alzheimers Dement. 2025 Feb;21(2):e14535. doi: 10.1002/alz.14535.
8
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.TMEM106B 和 CPOX 是脑脊液阿尔茨海默病生物标志物水平的遗传决定因素。
Alzheimers Dement. 2021 Oct;17(10):1628-1640. doi: 10.1002/alz.12330. Epub 2021 May 14.
9
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.评估激肽释放酶 6 作为阿尔茨海默病的横断面和纵向生物标志物。
Alzheimers Res Ther. 2018 Jan 29;10(1):9. doi: 10.1186/s13195-018-0336-4.
10
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.在纵向随访的轻度认知障碍和阿尔茨海默病患者中,血浆载脂蛋白 E 水平。
Alzheimers Res Ther. 2022 Aug 24;14(1):115. doi: 10.1186/s13195-022-01058-9.

引用本文的文献

1
Single-Cell Transcriptomic Profiling of Brain Cells in Newborn Rats Following Hypoxic Ischemic Encephalopathy.缺氧缺血性脑病后新生大鼠脑细胞的单细胞转录组分析
FASEB J. 2025 Aug 31;39(16):e70929. doi: 10.1096/fj.202402891RR.

本文引用的文献

1
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease.对人类脑脊液的蛋白质基因组分析确定了与神经学相关的调控,并揭示了阿尔茨海默病的因果蛋白。
Nat Genet. 2024 Dec;56(12):2672-2684. doi: 10.1038/s41588-024-01972-8. Epub 2024 Nov 11.
2
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests.阿尔茨海默病的高精度血液检测在准确性上可与临床脑脊液检测相媲美或优于后者。
Nat Med. 2024 Apr;30(4):1085-1095. doi: 10.1038/s41591-024-02869-z. Epub 2024 Feb 21.
3
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.
脑脊液可溶性 TREM2 的蛋白质组学研究为阿尔茨海默病提供了新的见解,并确定了新的调节剂。
Mol Neurodegener. 2024 Jan 3;19(1):1. doi: 10.1186/s13024-023-00687-4.
4
Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status.比较常用的血浆和脑脊液蛋白及其对认知障碍特征的意义。
J Alzheimers Dis. 2024;97(2):621-633. doi: 10.3233/JAD-230837.
5
Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study.比较脑脊液和血浆 NfL 和 pNfH 对阿尔茨海默病的诊断价值:一项记忆门诊研究。
J Neurol. 2024 Mar;271(3):1297-1310. doi: 10.1007/s00415-023-12066-6. Epub 2023 Nov 11.
6
Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer's pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform.使用 Lumipulse 自动化平台,血浆 Aβ40、Aβ42 和 p-tau181 检测认知正常受试者 CSF 阿尔茨海默病病理改变的准确性。
Alzheimers Res Ther. 2023 Oct 2;15(1):163. doi: 10.1186/s13195-023-01319-1.
7
Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology.阿尔茨海默病生物标志物:从 CSF 到血浆的可靠检测淀粉样蛋白和 tau 病理变化。
Clin Chem. 2023 Nov 2;69(11):1247-1259. doi: 10.1093/clinchem/hvad139.
8
Genetic architecture of plasma Alzheimer disease biomarkers.血浆阿尔茨海默病生物标志物的遗传结构。
Hum Mol Genet. 2023 Jul 20;32(15):2532-2543. doi: 10.1093/hmg/ddad087.
9
Correlations between kynurenines in plasma and CSF, and their relation to markers of Alzheimer's disease pathology.血浆和脑脊液中犬尿氨酸的相关性及其与阿尔茨海默病病理标志物的关系。
Brain Behav Immun. 2023 Jul;111:312-319. doi: 10.1016/j.bbi.2023.04.015. Epub 2023 May 4.
10
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.